Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

243.45 -1.10 (-0.45%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

Nanobiotix-J&J Therapy Shows Promise In Tough Head And Neck Cancer ↗

September 30, 2025

Nanobiotix reported updated Phase 1 trial data for JNJ-1900 in head and neck cancer, showing strong disease control and survival outcomes.

Via Benzinga

Wall Street Defies D.C. Drama: Strong Gains Persist Amidst Looming Government Shutdown

September 30, 2025

As the clock ticks towards the critical September 30, 2025, fiscal year-end deadline, Washington D.C. finds itself embroiled in familiar budget battles, once again raising the specter of a U.S....

Via MarketMinute

Navigating the Tempest: Market Volatility and the Shifting Sands of Stock Futures

September 30, 2025

As of late September 2025, global financial markets find themselves in a turbulent sea, characterized by persistent volatility and nuanced trends in stock futures. A complex interplay of macroeconomic...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Dollar Dips as Government Shutdown Looms: A Volatile Start to Q4 2025

September 29, 2025

The US dollar experienced a notable weakening against major global currencies today, September 29, 2025, marking a significant shift after a period of sustained strength. This decline is largely...

Via MarketMinute

Topics Bonds Economy Government

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

The U.S. pharmaceutical industry is at the center of a policy maelstrom.

Via Benzinga

Topics ETFs

Why Johnson & Johnson Could Be the Ultimate Dividend King ↗

September 28, 2025

Johnson & Johnson has increased its dividend every year for 63 consecutive years. It doesn't want to stop.

Via The Motley Fool

U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears

September 29, 2025

As the clock ticks towards the September 30, 2025, funding deadline, the United States federal government finds itself perilously close to another shutdown. Congressional leaders remain deadlocked on a...

Via MarketMinute

Topics Bonds Economy Government

Is Palantir Technologies Stock a Buy Now? ↗

September 28, 2025

The stock is once again nearing an all-time high, but the valuation is untenable.

Via The Motley Fool

Topics Artificial Intelligence

Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers

September 27, 2025

In a hypothetical scenario playing out just last week, leading up to September 27, 2025, Johnson & Johnson (NYSE: JNJ) experienced a significant stock rally, capturing the attention of investors and...

Via MarketMinute

Topics Economy Intellectual Property

US Government Braces for Unprecedented Shutdown: Economic Fallout Looms as Deadline Nears

September 27, 2025

As the clock ticks towards midnight on September 30, 2025, the United States government stands on the precipice of a highly imminent and seemingly unavoidable shutdown. With just days left until the...

Via MarketMinute

Topics Economy Government Workforce

The Phoenix Play: Unearthing Beaten-Down Stocks for a Powerful Comeback

September 27, 2025

In the dynamic landscape of financial markets, the allure of finding deeply discounted assets with a strong potential for recovery remains a cornerstone of successful investment strategies. As of...

Via MarketMinute

Topics Bankruptcy Earnings Economy

Jabils AI-Driven Boom Has Begun: News Highs are Coming ↗

September 26, 2025

Jabil is well-positioned to benefit from the long-term demand driven by AI and its impact on technology at all levels. Analysts are leading this market higher.

Via MarketBeat

Topics Artificial Intelligence

Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years? ↗

September 26, 2025

There is a lot to like about this healthcare company, but that goal might be beyond its powers.

Via The Motley Fool

Topics Intellectual Property

Global Markets Brace for Impact as New U.S. Tariffs Escalate Trade Tensions Amidst Geopolitical Volatility

September 26, 2025

September 26, 2025 – Global financial markets are once again in the throes of uncertainty as the United States unveils a fresh wave of substantial trade tariffs, set to take effect on October 1, 2025....

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity ↗

September 25, 2025

Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE: JNJ) revealed 17 unusual trades.

Via Benzinga

What's Driving the Market Sentiment Around Johnson & Johnson? ↗

September 25, 2025

Johnson & Johnson's (NYSE: JNJ) short interest as a percent of float has risen 17.95% since its last report. According to exchange reported data, there are now 22.05 million shares sold short, which is...

Via Benzinga

US Stocks Grapple with Quarter-End Jitters, Two-Day Losing Streak Tests Market Resolve

September 25, 2025

New York, NY – September 25, 2025 – As the third quarter of 2025 rapidly approaches its conclusion, U.S. stock markets are navigating a challenging period, marked by a two-day losing streak that...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Market Tremors: Dow, S&P 500, and Nasdaq Endure Third Straight Day of Losses Amidst Economic Headwinds

September 25, 2025

New York, NY – September 25, 2025 – Major U.S. stock indices, including the Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite, have registered their third consecutive day of declines,...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Johnson & Johnson (NYSE:JNJ) Shows Strong Technical Setup for Potential Breakout ↗

September 25, 2025

Johnson & Johnson (JNJ) shows a strong technical uptrend and a high-quality consolidation pattern, signaling a potential breakout as it trades near 52-week highs.

Via Chartmill

These 3 Dow Stocks Are Set to Soar in 2025 and Beyond ↗

September 25, 2025

The proverbial planets are aligning for each of their underlying companies.

Via The Motley Fool

Topics Artificial Intelligence Stocks

3 Exceptional High-Yielding Dividend Kings That Have Been Increasing Their Payouts for Over 60 Years ↗

September 25, 2025

Not only have these stocks raised their dividends consistently, but they also offer above-average yields.

Via The Motley Fool

Topics Economy

Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects

September 24, 2025

Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence...

Via MarketMinute

Topics Government Product Recall

Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies ↗

September 24, 2025

A judge upholds Maine's contract pharmacy law, rejecting drugmakers' claims that it conflicts with federal rules governing the 340B drug discount program.

Via Benzinga

Johnson & Johnson Is Attacking 2022 Highs ↗

September 24, 2025

Johnson & Johnson is attacking 2022 highs, as we see it rising impulsively, ideally unfolding a five-wave bullish cycle of different degrees by the Elliott wave model.

Via Talk Markets

Trump’s Tylenol Warning Sparks FDA Action, But Kenvue Stock Climbs: Retail Traders See ‘Huge Buying Opportunity’ ↗

September 23, 2025

Kenvue is facing renewed litigation risks, activist investor pressure, and a challenging consumer backdrop as it undertakes a portfolio review under interim CEO Kirk Perry.

Via Stocktwits

Topics Economy Government Lawsuit

The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗

September 23, 2025

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

Via Benzinga

Jabil Set For Major AI Growth As Other Segments Falter: Analyst ↗

September 23, 2025

Jabil Inc. to report fiscal Q4 earnings; AI and cloud revenue key factors for outlook. Analyst expects conservative guidance.

Via Benzinga

Topics Artificial Intelligence

Evolving Investment Strategies for an Uncertain Market

September 23, 2025

In an era marked by persistent inflation, fluctuating interest rates, geopolitical tensions, and rapid technological shifts, investors are facing an increasingly complex and unpredictable financial...

Via MarketMinute

Topics Bonds ETFs Economy

This Johnson & Johnson Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

September 23, 2025

Via Benzinga

Johnson & Johnson Ends Overseas Sales Of Acid Reflux Device Citing Market Factors ↗

September 23, 2025

Johnson & Johnson will halt international sales of its Linx reflux device, sparking concern among surgeons over limited options for GERD patients.

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Johnson & Johnson (NY:JNJ)

All News about Johnson & Johnson

Starting at $3.75/week.

Subscribe Today